Drug intelligence / Profile preview

adeno-associated virus serotype 4

Development stage
Preclinical
Lead developer
Pluriomics
Modality
Gene Therapies
Administration
Intravenous, Intracerebroventricular, Intravitreal, Intramuscular
01

Overview

Adeno-associated virus serotype 4 (AAV4) is a viral vector platform utilized in gene therapy to deliver therapeutic genetic material to specific tissues. Derived from the Parvoviridae family, AAV4 is characterized by its unique cellular tropism, which is mediated by binding to O-linked sialic acid on the surface of target cells. It has shown particular efficiency in transducing the ependymal lining of the ventricles in the central nervous system and the retinal pigmented epithelium in the eye. In comparative studies for cardiac gene delivery, AAV4 has demonstrated lower transduction efficiency in cardiomyocytes compared to other serotypes like AAV1, AAV6, or AAV9. As a replication-deficient vector, it is engineered to provide long-term transgene expression with a low immunogenic profile.

Other names
adeno-associated virus 4
02

Targets

SA (Sialic acid)

Beyond the preview

Go deeper on adeno-associated virus serotype 4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adeno-associated virus serotype 4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call